Log in to save to my catalogue

Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exch...

Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exch...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1080_0886022X_2023_2210691

Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exchange in patients with increased bleeding risk

About this item

Full title

Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exchange in patients with increased bleeding risk

Publisher

England: Taylor & Francis

Journal title

Renal failure, 2023-12, Vol.45 (1), p.2210691-2210691

Language

English

Formats

Publication information

Publisher

England: Taylor & Francis

More information

Scope and Contents

Contents

Background Heparin anticoagulation (HA) is commonly employed for membrane therapeutic plasma exchange (mTPE). However, for patients with increased bleeding risk, there were controversial opinions on the use of HA versus regional citrate anticoagulation (RCA) for mTPE. Our present study aimed to evaluate the efficacy and safety of HA vs. RCA for mTP...

Alternative Titles

Full title

Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exchange in patients with increased bleeding risk

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1080_0886022X_2023_2210691

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1080_0886022X_2023_2210691

Other Identifiers

ISSN

0886-022X

E-ISSN

1525-6049

DOI

10.1080/0886022X.2023.2210691

How to access this item